Kevin Sharer

Amgen (AMGN)
2007 compensation: $19.9 million
YTD share performance: 17.66%
Net income, One-Year Growth: 28.6%

Amgen has seen both its stock and net income go up this year, which is no small feat. At a meeting with analysts and investors in early November, management gave a healthy outlook and outlined a growth strategy for the next two years, focusing on delivering on its pipeline of new drugs.

Candy Cane or Coal?: Candy Cane